1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2:

Frequency and severity of unilateral brain abnormalities in patients with Parry-Romberg syndrome and epilepsy compared with cases without epilepsya

Nonepilepsy (n = 64)Epilepsy (n = 16)P Value CategoriesP Value Overall
Hemispheric atrophy
    None61 (95%)8 (50%)<.001<.001
    Mild1 (1.6%)1 (6%)
    Moderate1 (1.6%)3 (19%)
    Severe1 (1.6%)4 (25%)
WMD
    None49 (77%)2 (12%)<.001<.001
    Mild10 (15%)7 (44%)
    Moderate2 (3%)4 (25%)
    Severe3 (5%)3 (19%)
Hemispheric microhemorrhage
    None61 (95%)13 (81%).015.091
    Mild3 (5%)1 (6%)
    Moderate00
    Severe02 (12%)
Leptomeningeal enhancement
    Absent63 (98%)15 (94%).362
    Present1 (1.6%)1 (6%)
  • a Some patients had more than 1 finding.